The short version of incretin receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-26. Anything still debated is marked as such rather than presented as settled.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Includes the 39-residue backbone and the attached fatty diacid |
| Molecular weight | Approximately 4813 Da | Average mass; the monoisotopic value is slightly lower |
| Receptor targets | GIP receptor and GLP-1 receptor | Dual engagement defines the pharmacological class |
| Backbone length | 39 amino acids | Sequence modified from native glucose-dependent insulinotropic polypeptide |
| Albumin interaction | Reversible, mediated by the fatty diacid | Slows renal clearance and lengthens circulation time |
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Another area he developed was porpos polymers from high internal phase emulsions (PolyHIPEs), particularly as applied to solid phase peptide synthesis. Sherrington returned to Strathclyde in 1987 as a full professor and later the head of the organic chemistry section. His reputation grew and he was to hold visiting chairs in 10 universities around the world. He was awarded a DSc by his alma mater, and elected a Fellow of the Royal Societies of Edinburgh and London. In their memoir of Sherrington Randal W. Richards and Philip Hodge note, that “It is very evident that David Sherrington made a major and unique impact on polymer science by enthusiastically bringing the rigour of physical chemistry to a new and rapidly expanding area of the subject and by being keen to collaborate with experts in other Disciplines”. David Colin Carrington suffered from pain in his lower back for many years, and was finally diagnosed in April 2012 as having multiple system atrophy (MSA). He had two major attacks of pneumonia in 2014 and died on 4 October, survived by Val. They had no children. Val has continued to raise awareness of MSA.
=== Tenure === Upon the opening of the 118th United States Congress on January 3, 2023, Schmitt was sworn in by Senate president and Vice President Kamala Harris. He tweeted that he was honored to be the 2,000th senator to hold office in the history of the Senate. Schmitt was among the 31 Senate Republicans who voted against final passage of the Fiscal Responsibility Act of 2023, a bill to raise the debt ceiling. In February 2025, when NBC's Kristen Welker asked Schmitt the same question posed to Tulsi Gabbard during her Director of National Intelligence confirmation hearing—whether he would call Edward Snowden a traitor—he said many asking this oppose Gabbard because she would "reform and curb the excesses and the worst instincts of the intelligence community that at times has gone after presidential candidates". Later that month, after Trump called Ukrainian president Volodymyr Zelenskyy a "dictator" and said Ukraine was at fault for the Ukraine war, Schmitt said Zelenskyy should not be "openly criticizing" Trump and should "stop lecturing" him. Schmitt said Trump had spoken "a lot on the campaign trail" about "trying to negotiate a peace deal between Russia and Ukraine. ... He's a master negotiator, and I think he's going to get to a lasting peace." According to ABC News, Schmitt was the only Republican senator "to seemingly offer both support for Trump and the premise of his statements on Ukraine and Russia". At the start of the 119th Congress in 2025, Schmitt hired Nate Hochman as a staffer.
On the other hand, in the case of complete myeloperoxidase deficiency, DHR test gives abnormal results (false positive for CGD) because the DHR signal yielded by flow cytometry depends on intact NADPH oxidase activity as well as the presence of a myeloperoxidase (MPO); however, NBT test demonstrates normal production of superoxide. Genetic testing: Once CGD has been diagnosed based on abnormal neutrophil function tests, genetic testing should go next. As mentioned above, p47phox defect is usually difficult to identify genetically because it is caused by pseudogene conversion and may be missed in typical sequencing studies; in this case, immunoblotting or flow cytometry can show absence of protein. Prenatal testing: It is particularly useful when a family member has already been diagnosed with CGD. This test may be performed by analysis of NADPH oxidase activity of neutrophils from fetal blood. Samples from amniotic fluid or chorionic villi provides an earlier and more reliable diagnosis for families at risk.
On 19 June, Nasrallah stated that a Hezbollah invasion of the Galilee "remains on the table" and alleged that the government of Cyprus was allowing Israeli forces to operate within its country and thus made Cyprus a legitimate target for Hezbollah strikes. Cypriot president Nikos Christodoulides denied that Cyprus was taking sides in the conflict. On 30 June, Israeli officials reported 18 IDF soldiers were wounded by a drone attack on the Golan Heights. The inability of Israelis to return to settlements and homes in the north of the country led to Antony Blinken stating that Israel had effectively "lost sovereignty in the northern quadrant of its country". On 3 July, senior Hezbollah field commander Mohammed Nasser was killed in an Israeli airstrike in Tyre, and in response Hezbollah fired 100 rockets at IDF positions. The following day, it fired 200 more rockets into Israel. On 9 July, an Israeli airstrike on the Beirut–Damascus highway in Syria killed two Hezbollah members, and Hezbollah fired 40 rockets at the Golan Heights. A week later, at least two people were wounded in an Israeli drone attack in Lebanon, and Hezbollah rocket strikes in Kiryat Shmona damaged residential buildings. On 22 July, drones from Lebanon were intercepted by Israeli forces, and a Hezbollah rocket strike injured two soldiers in northern Israel. The following day and in response, Israel launched artillery strikes on southern Lebanon, Hezbollah launched rocket strikes in northern Israel, and Israeli warplanes and artillery struck southern Lebanon.
In 2010, it was estimated that about 250,000 t of nuclear HLW were stored globally. This does not include amounts that have escaped into the environment from accidents or tests. Japan is estimated to hold 17,000 t of HLW in storage in 2015. As of 2019, the United States has over 90,000 t of HLW. HLW have been shipped to other countries to be stored or reprocessed and, in some cases, shipped back as active fuel. The ongoing controversy over high-level radioactive waste disposal is a major constraint on nuclear power global expansion. Most scientists agree that the main proposed long-term solution is deep geological burial, either in a mine or a deep borehole. As of 2019, no dedicated civilian high-level nuclear waste site is operational as small amounts of HLW did not justify the investment in the past. Finland is in the advanced stage of the construction of the Onkalo spent nuclear fuel repository, which is planned to open in 2025 at 400–450 m depth. France is in the planning phase for a 500 m deep Cigeo facility in Bure. Sweden is planning a site in Forsmark. Canada plans a 680 m deep facility near Lake Huron in Ontario. The Republic of Korea plans to open a site around 2028. The site in Sweden enjoys 80% support from local residents as of 2020. The Morris Operation in Grundy County, Illinois, is currently the only de facto high-level radioactive waste storage site in the United States.
Sources: en.wikipedia.org
== History == In 2012, the Committee for Medicinal Products for Human Use (CHMP) of the EMA issued a positive opinion on the drug. Dapagliflozin was found effective in several studies in participants with type 2 diabetes. The main measure of effectiveness was the level of glycated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. In two studies involving 840 participants with type 2 diabetes, dapagliflozin when used alone decreased HbA1c levels by 0.66% more than placebo (a dummy treatment) after 24 weeks. In four other studies involving 2,370 participants, adding dapagliflozin to other diabetes medicines decreased HbA1c levels by 0.54–0.68% more than adding placebo after 24 weeks. In a study involving 814 participants with type 2 diabetes, dapagliflozin used in combination with metformin was at least as effective as a sulphonylurea (another type of diabetes medicine) used with metformin. Both combinations reduced HbA1c levels by 0.52% after 52 weeks. A long-term study, involving over 17,000 participants with type 2 diabetes, looked at the effects of dapagliflozin on cardiovascular (heart and circulation) disease. The study indicated that dapagliflozin's effects were in line with those of other diabetes medicines that also work by blocking SGLT2. In two studies involving 1,648 participants with type 1 diabetes whose blood sugar was not controlled well enough on insulin alone, adding dapagliflozin 5 mg decreased HbA1c levels after 24 hours by 0.37% and by 0.42% more than adding placebo.
==== Natural analogues ==== Natural analogues of nicotine, often found in plants or other biological sources, include anabasine (from Anabasis aphylla), anatabine (from tobacco), arecoline (from betel nut), cotinine (major metabolite of nicotine), cytisine (from Laburnum species), and epibatidine (from frog skin), among others.
== Financial information == From the founding of the company in 1976 to 1988, the revenue of KCI grew to US$153.2 million. The growth in revenue allowed KCI to go public and trade on the New York Stock Exchange (NYSE) in 1988. KCI stock was traded on the NYSE until 1997, when the company went private. In February 2004, KCI became a publicly listed company for the second time and was listed on the NYSE under the ticker symbol KCI. By the late 2000s, the company's revenue was over $1 billion and reported an increase of 17 percent in 2007 to $1.61 billion. Revenue for 2008 was $1.88 billion, increasing to $1.99 billion in 2009 and in 2010 increased to $2.02 billion. On November 4, 2011, the company went private again at a price of $68.50 per share.
Clostridium botulinum Clostridium perfringens Bacillus cereus The rare but potentially deadly disease botulism occurs when the anaerobic bacterium Clostridium botulinum grows in improperly canned low-acid foods and produces botulin, a powerful paralytic toxin. Pseudoalteromonas tetraodonis, certain species of Pseudomonas and Vibrio, and some other bacteria, produce the lethal tetrodotoxin, which is present in the tissues of some living animal species rather than being a product of decomposition.
Sources: en.wikipedia.org
=== Other governmental positions === Mizell became the Assistant Secretary of Agriculture for Governmental and Public Affairs on August 23, 1982. He was the Agriculture Department's top lobbyist during the Reagan administration. Later he was appointed as Deputy Assistant Secretary for Intergovernmental Affairs in the Department of Veterans Affairs in the George H. W. Bush administration. In 1989, he became the executive director of the President's Council on Physical Fitness and Sports. In this role, he supported the Healthy People 2000 aims of reducing preventable deaths and disabilities. He also helped start local physical fitness and sports councils around the country.
In now discredited work, Fredrickson and Losada postulated in 2005 that the ratio of positive to negative affect, known as the critical positivity ratio, can distinguish individuals that flourish from those that do not. Languishing was characterized by a ratio of positive to negative affect of 2.5. Optimal functioning or flourishing was argued to occur at a ratio of 4.3. The point at which flourishing changes to languishing is called the Losada line and is placed at the positivity ratio of 2.9. Those with higher ratios were claimed to have broader behavioral repertoires, greater flexibility and resilience to adversity, more social resources, and more optimal functioning in many areas of their life. The model also predicted the existence of an upper limit to happiness, reached at a positivity ratio of 11.5. Fredrickson and Losada claimed that at this limit, flourishing begins to disintegrate and productivity and creativity decrease. They suggested as positivity increased, so to "appropriate negativity" needs to increase. This was described as time-limited, practicable feedback connected to specific circumstances, i.e. constructive criticism. This positivity ratio theory was widely accepted until 2013, when Nick Brown, a graduate student in applied positive psychology, co-authored a paper with Alan Sokal and Harris Friedman, showing that the mathematical basis of the paper was invalid. Fredrickson partially retracted the paper, agreeing that the math may be flawed, but maintaining that the empirical evidence is still valid.
== Awards == She was awarded the Agnes Fay Morgan Research Award in 1995. In 2019, Brodbelt received the Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry from the American Chemical Society. In 2023, she was named one of the "Mentors and Educators" in the Power List by the Analytical Scientist. In 2024, she was awarded the Thomson Medal by the International Mass Spectrometry Foundation.
Modern practice therefore often involves an iterative process: field lichenologists may initially distinguish entities by appearance ("morphospecies"), then genetic analysis (often multilocus) is used to test those hypotheses, merging or splitting as needed. Others invert the sequence: barcode data first reveal genetic clusters, which are then searched for overlooked diagnostic traits ("L then P"). Either way, multiple evidence lines—rather than their order—are the requirement. Coalescent-based models now estimate how many genetic lineages in a lichen group merit species rank. The models incorporate incomplete lineage sorting and ongoing gene flow. Results usually recognize more species than morphology alone, suggesting widespread cryptic speciation. A purely genetic approach can oversplit when it treats every population divergence as a new species. Lücking and colleagues (2021) warn that genome-scale data make every population diagnosable; genetic structure must therefore be interpreted biologically to avoid a proliferation of trivial taxa. They advocate pairing genetics with quantitative phenotype data (morphometrics, metabolite profiles) to test discontinuities and confirm genuine species boundaries.
=== Bossa and Vertigo === By September 2017, Faliszek had joined London-based Bossa Studios, and led Bossa's new Seattle-based studio. He was working on an unannounced cooperative game that is "trying to do something new in the narrative space using [artificial intelligence]". In May 2018, Faliszek announced he had also joined the board of advisers for Vertigo Games, and will help support a virtual reality title they are currently developing. After about a year at Bossa, Faliszek and Bossa agreed that what Faliszek had planned was not working out, in part due to his envisioned game not being the type of product Bossa had worked on before, and Faliszek left the company early in 2019. By March 2019, he founded a new studio, Stray Bombay Company, along with Riot Games' Kimberly Voll, in essence to continue the development of the cooperative title. Faliszek had previously met Voll around 2012 while Valve was exploring the VR space, and had helped Voll get Radial Games Fantastic Contraption as a SteamVR launch title. Faliszek found Voll's focus on player interaction a key part of his idea for the cooperative game. Stray Bombay was backed financially by both Riot and Upfront Ventures. The company's first game is The Anacrusis, which was released via early access in January 2022, and fully launched December 5th, 2023. Starting around 2023, Faliszek began to post TikToks and YouTube videos about his time at Valve, experiences in the games industry, and his views on game design. He would make a video about Stop Killing Games, disagreeing with the movement.
Sources: en.wikipedia.org
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.
Engaging two receptors recruits signaling pathways that only partly coincide. This can shift the magnitude of effects on insulin release, glucagon levels and appetite relative to selective agents. Whether the pairing delivers benefits beyond a simple sum of the two is still debated in the literature.
The proportional contribution of each receptor to observed clinical effects has not been fully separated. Long-term consequences of continuous dual stimulation are likewise unclear. Investigators continue to probe these points through laboratory and clinical work.
It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.